STATE OF WISCONSIN INVESTMENT BOARD - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 102 filers reported holding POSEIDA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
STATE OF WISCONSIN INVESTMENT BOARD ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$134,223
+113.1%
43,579
+79.2%
0.00%
Q2 2022$63,000
-64.8%
24,322
-39.2%
0.00%
Q1 2022$179,000
+30.7%
40,000
+112.8%
0.00%
Q3 2021$137,000
-27.1%
18,8000.0%0.00%
Q2 2021$188,000
+4.4%
18,8000.0%0.00%
Q1 2021$180,000
-12.6%
18,8000.0%0.00%
Q4 2020$206,00018,8000.00%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$10,454,0001.67%
Boxer Capital, LLC 1,251,055$12,536,0000.44%
Pentwater Capital Management LP 4,967,227$49,772,0000.41%
KNOTT DAVID M 29,566$296,0000.10%
Perceptive Advisors 1,575,490$15,786,0000.10%
Virtus ETF Advisers LLC 24,287$243,0000.10%
Advisory Services Network, LLC 256,772$2,573,0000.08%
J. Goldman & Co LP 202,501$2,029,0000.08%
Ikarian Capital, LLC 85,837$861,0000.07%
Regent Investment Management LLC 25,000$251,0000.06%
View complete list of POSEIDA THERAPEUTICS INC shareholders